Menu
Search
|

Menu

Close
X

Lantheus Holdings Inc LNTH.OQ (NASDAQ Stock Exchange Global Market)

25.10 USD
+0.98 (+4.06%)
As of Mar 21
chart
Previous Close 24.12
Open 24.08
Volume 153,240
3m Avg Volume 98,742
Today’s High 25.18
Today’s Low 23.99
52 Week High 25.42
52 Week Low 12.60
Shares Outstanding (mil) 38.63
Market Capitalization (mil) 931.72
Forward P/E 23.51
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.67 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY18
343
FY17
331
FY16
302
EPS (USD)
FY18
1.026
FY17
0.981
FY16
0.841
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
23.51
58.82
Price to Sales (TTM)
vs sector
2.71
9.06
Price to Book (MRQ)
vs sector
13.07
4.61
Price to Cash Flow (TTM)
vs sector
17.11
40.52
Total Debt to Equity (MRQ)
vs sector
375.28
17.60
LT Debt to Equity (MRQ)
vs sector
371.41
13.95
Return on Investment (TTM)
vs sector
11.19
12.09
Return on Equity (TTM)
vs sector
85.94
13.20

EXECUTIVE LEADERSHIP

Brian Markison
Non-Executive Independent Chairman of the board, Since 2013
Salary: --
Bonus: --
Mary Heino
President, Chief Executive Officer, Director, Since 2015
Salary: $629,230.00
Bonus: --
Robert Marshall
Chief Financial Officer, Treasurer, Since 2018
Salary: --
Bonus: --
Michael Duffy
Senior Vice President, Strategy and Business Development, General Counsel and Secretary, Since 2015
Salary: $391,397.00
Bonus: --
Sarah Roy
Senior Vice President, Human Resources, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

331 Treble Cove Rd
NORTH BILLERICA   MA   01862-2849

Phone: +1978.6718001

Lantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.

SPONSORED STORIES